JP2010516779A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010516779A5 JP2010516779A5 JP2009547377A JP2009547377A JP2010516779A5 JP 2010516779 A5 JP2010516779 A5 JP 2010516779A5 JP 2009547377 A JP2009547377 A JP 2009547377A JP 2009547377 A JP2009547377 A JP 2009547377A JP 2010516779 A5 JP2010516779 A5 JP 2010516779A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- substituent
- compound
- con
- hydroxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 18
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 206010030043 Ocular hypertension Diseases 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- -1 chloro, bromo, hydroxymethyl Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 150000007524 organic acids Chemical group 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88601307P | 2007-01-22 | 2007-01-22 | |
| US60/886,013 | 2007-01-22 | ||
| PCT/US2008/051650 WO2008091860A1 (en) | 2007-01-22 | 2008-01-22 | Thiophene derivatives useful as ocular hypotensive agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010516779A JP2010516779A (ja) | 2010-05-20 |
| JP2010516779A5 true JP2010516779A5 (enExample) | 2011-03-10 |
| JP5394933B2 JP5394933B2 (ja) | 2014-01-22 |
Family
ID=39420781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009547377A Expired - Fee Related JP5394933B2 (ja) | 2007-01-22 | 2008-01-22 | 眼圧降下剤として有用なチオフェン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8039496B2 (enExample) |
| EP (1) | EP2114913B1 (enExample) |
| JP (1) | JP5394933B2 (enExample) |
| AT (1) | ATE511506T1 (enExample) |
| AU (1) | AU2008207991B9 (enExample) |
| CA (1) | CA2675981A1 (enExample) |
| WO (1) | WO2008091860A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007272683B2 (en) * | 2006-07-10 | 2012-08-23 | Allergan, Inc. | Substituted cyclopentane derivatives as therapeutic agents |
| US7803798B2 (en) * | 2008-04-24 | 2010-09-28 | Allergan, Inc. | Therapeutic compounds |
| EP2297085B1 (en) * | 2008-04-24 | 2019-03-20 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
| ES2693255T3 (es) * | 2014-02-27 | 2018-12-10 | Ono Pharmaceutical Co., Ltd. | Compuesto que presenta actividad agonista de EP2 selectiva |
| JP6773035B2 (ja) | 2015-07-23 | 2020-10-21 | 小野薬品工業株式会社 | Ｅｐ２アゴニスト活性を有する化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US6291522B1 (en) * | 2000-09-27 | 2001-09-18 | Allergan Sales, Inc. | Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| ES2246419T3 (es) * | 2001-11-05 | 2006-02-16 | Allergan, Inc. | Analogos de omega-cicloalquil-17-heteroaril-prostaglandina e2 como agonistas del receptor ep-2. |
| US7183310B2 (en) * | 2004-08-10 | 2007-02-27 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US7101904B2 (en) * | 2004-08-10 | 2006-09-05 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US7091231B2 (en) | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| BRPI0713587A2 (pt) * | 2006-06-20 | 2012-10-23 | Allergan Inc | descrição de compostos terapêuticos da invenção |
| US7507817B2 (en) * | 2006-11-17 | 2009-03-24 | Allergan, Inc. | Prostaglandin prodrugs |
| US7803798B2 (en) * | 2008-04-24 | 2010-09-28 | Allergan, Inc. | Therapeutic compounds |
| EP2297085B1 (en) * | 2008-04-24 | 2019-03-20 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
-
2008
- 2008-01-22 CA CA002675981A patent/CA2675981A1/en not_active Abandoned
- 2008-01-22 EP EP08713891A patent/EP2114913B1/en not_active Not-in-force
- 2008-01-22 JP JP2009547377A patent/JP5394933B2/ja not_active Expired - Fee Related
- 2008-01-22 US US12/523,409 patent/US8039496B2/en active Active
- 2008-01-22 WO PCT/US2008/051650 patent/WO2008091860A1/en not_active Ceased
- 2008-01-22 AT AT08713891T patent/ATE511506T1/de not_active IP Right Cessation
- 2008-01-22 AU AU2008207991A patent/AU2008207991B9/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009543795A5 (enExample) | ||
| JP2010530897A5 (enExample) | ||
| IL264541A (en) | History of sulfamolepyrolamide and their use as drugs for the treatment of jaundice b | |
| JP2016518434A5 (enExample) | ||
| JP2009541340A5 (enExample) | ||
| JP2011500818A5 (enExample) | ||
| JP2009527501A5 (enExample) | ||
| JP2011518775A5 (enExample) | ||
| JP2010540477A5 (enExample) | ||
| WO2006098918B1 (en) | Substituted gamma lactams as therapeutic agents | |
| JP2009526034A5 (enExample) | ||
| JP2009519903A5 (enExample) | ||
| JP2010500976A5 (enExample) | ||
| JP2013509487A5 (enExample) | ||
| JP2012503016A5 (enExample) | ||
| JP2010535870A5 (enExample) | ||
| JP2009535426A5 (enExample) | ||
| JP2004524340A5 (enExample) | ||
| NO20080739L (no) | Fremgangsmater for behandling av Epileptogenese | |
| JP2010510232A5 (enExample) | ||
| JP2013521301A5 (enExample) | ||
| JP2009543794A5 (enExample) | ||
| JP2007519618A5 (enExample) | ||
| JP2009184932A5 (enExample) | ||
| EA200800294A1 (ru) | Способы нейропротекции |